Skip to main content
Sun Pharmaceutical Industries Limited (BOM:524715)
India flag India · Delayed Price · Currency is INR
1,804.95
-13.65 (-0.75%)
At close: Dec 5, 2025

BOM:524715 Revenue

Sun Pharmaceutical Industries had revenue of 144.78B INR in the quarter ending September 30, 2025, with 8.93% growth. This brings the company's revenue in the last twelve months to 549.64B, up 9.26% year-over-year. In the fiscal year ending March 31, 2025, Sun Pharmaceutical Industries had annual revenue of 525.78B with 8.42% growth.

Revenue (ttm)
549.64B
Revenue Growth
+9.26%
P/S Ratio
7.88
Revenue / Employee
12.78M
Employees
43,000
Market Cap
4,331.52B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025525.78B40.82B8.42%
Mar 31, 2024484.97B46.11B10.51%
Mar 31, 2023438.86B52.31B13.53%
Mar 31, 2022386.54B51.56B15.39%
Mar 31, 2021334.98B6.61B2.01%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Reliance Industries 9,996.29B
HDFC Bank 2,683.70B
Bharti Airtel 1,946.14B
Tata Consultancy Services 2,576.88B
ICICI Bank 1,909.34B
State Bank of India 3,571.95B
Infosys 1,748.84B
Bajaj Finance 406.39B
Revenue Rankings

Sun Pharmaceutical Industries News

More News